A detailed history of Mqs Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mqs Management LLC holds 1,296 shares of VRTX stock, worth $590,081. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,296
Previous 961 34.86%
Holding current value
$590,081
Previous $401,000 51.37%
% of portfolio
0.37%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $131,591 - $162,652
335 Added 34.86%
1,296 $607,000
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $391,790 - $428,682
961 New
961 $401,000
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $693,539 - $780,231
2,427 New
2,427 $700,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $117B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mqs Management LLC Portfolio

Follow Mqs Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.